Achillion Pharmaceuticals, Inc. (ACHN) Posts Q1 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Total operating expenses: 21.55M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Total operating expenses: 21.55M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Immucell Corp (ICCC) Reports Q2 EPS of $0.20
- Actelis Networks (ASNS) Tops Q2 EPS by 63c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
